Rezultaty - Axel Wester

  • Rezultaty 1 - 13 Rezultaty od 13
Redukuj rezultaty
  1. 1
    Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients

    Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients od Hanne Åström, Axel Wester, Hannes Hagström

    Wydane 2023
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  2. 2
    Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER)

    Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER) od Hannes Hagström, Ying Shang, Axel Wester, Linnea Widman

    Wydane 2022
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  3. 3
    Persons with metabolic dysfunction‐associated steatotic liver disease are at increased risk of severe depression

    Persons with metabolic dysfunction‐associated steatotic liver disease are at increased risk of severe depression od Hanne Åström, Ying Shang, Hannes Hagström, Axel Wester

    Wydane 2024
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  4. 4
    Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population‐based cohort study

    Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population‐based cohort study od Johanna Schönau, Axel Wester, Jörn M. Schattenberg, Hannes Hagström

    Wydane 2023
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  5. 5
    Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden

    Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden od G. Issa, Ying Shang, Rickard Strandberg, Hannes Hagström, Axel Wester

    Wydane 2025
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  6. 6
    Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes

    Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes od Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony Matthews, Hannes Hagström

    Wydane 2024
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  7. 7
    Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease – A Population-based Cohort Study

    Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease – A Population-based Cohort Study od Fahim Ebrahimi, Tracey G. Simon, Hannes Hagström, Jonas Söderling, Axel Wester, Björn Roelstraete, Jonas F. Ludvigsson

    Wydane 2023
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  8. 8
    Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis

    Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis od Patrik Nasr, Axel Wester, Mattias Ekstedt, Rickard Strandberg, Stergios Kechagias, Ying Shang, Linnea Widman, Hannes Hagström

    Wydane 2024
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  9. 9
    Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes

    Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes od Juan Vaz, Patrik Nasr, Anders Helander, Ying Shang, Axel Wester, Rickard Strandberg, Emilie Toresson Grip, Hannes Hagström

    Wydane 2025
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  10. 10
    Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE‐SWEDEHEART Trial

    Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE‐SWEDEHEART Trial od Axel Wester, Rubina Attar, Moman A. Mohammad, Pontus Andell, Robin Hofmann, Jens Jensen, Karolina Szummer, David Erlinge, Sasha Koul

    Wydane 2019
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  11. 11
    Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up

    Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up od Magnus Holmer, Mattias Ekstedt, Patrik Nasr, Robin Zenlander, Axel Wester, Federica Tavaglione, Stefano Romeo, Stergios Kechagias, Per Stål, Hannes Hagström

    Wydane 2022
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  12. 12
    Liver stiffness predicts progression to liver‐related events in patients with chronic liver disease – A cohort study of 14 414 patients

    Liver stiffness predicts progression to liver‐related events in patients with chronic liver disease – A cohort study of 14 414 patients od Hannes Hegmar, Axel Wester, Soo Aleman, Jens Backman, Erik Degerman, Håkan Ekvall, Katarina Lund, Åsa Lundgren, Patrik Nasr, Afshin Shahnavaz, Johan Vessby, Johan Westin, Kristina Önnerhag, Hannes Hagström

    Wydane 2024
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  13. 13
    FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

    FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2 od Teresa Brevini, Mailis Maes, Gwilym J. Webb, Binu V. John, Claudia Fuchs, Gustav Buescher, Lu Wang, C. Griffiths, Marnie L. Brown, William E. Scott, Pehuén Pereyra-Gerber, William Gelson, Stephanie Brown, Scott Dillon, Daniele Muraro, Joanne Sharp, Megan Neary, Helen Box, Lee Tatham, James P. Stewart, Paul Curley, Henry Pertinez, Sally Forrest, Petra Mlčochová, Sagar Varankar, Mahnaz Darvish-Damavandi, Victoria Mulcahy, Rhoda E. Kuc, Thomas Williams, James A. Heslop, Davide Rossetti, Olivia Tysoe, Vasileios Galanakis, Marta Vilà González, Thomas W.M. Crozier, Johannes Bargehr, Sanjay Sinha, Sara Upponi, Corrina Fear, Lisa Swift, Kourosh Saeb‐Parsy, Susan Davies, Axel Wester, Hannes Hagström, Espen Melum, Darran Clements, Peter Humphreys, Jo Herriott, Edyta Kijak, Helen Cox, Chloe Bramwell, Anthony Valentijn, Christopher J. R. Illingworth, Bassam Dahman, Dustin Bastaich, Raphaella Ferreira, Thomas Marjot, Eleanor Barnes, Andrew M. Moon, A. Sidney Barritt, Ravindra K. Gupta, Stephen Baker, Anthony P. Davenport, Gareth Corbett, Vassilis G. Gorgoulis, Simon J.A. Buczacki, Joo‐Hyeon Lee, Nicholas J. Matheson, Michael Trauner, Andrew J. Fisher, Paul Gibbs, Andrew J. Butler, Christopher J.E. Watson, George Mells, Gordon Dougan, Andrew Owen, Ansgar W. Lohse, Ludovic Vallier, Fotios Sampaziotis

    Wydane 2022
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:

Narzędzie wyszukiwania: